论文部分内容阅读
《中国药典》1995版现已颁布实施,从而使我国药品质量向更高的水平迈进了一步。但仍有不少药材因检验项目太少,对保证药材内在质量尚显立法不足,从而可导致药材生产经营或中成药生产投料中低质劣药的泛滥和使用,最终影响药品的疗效。为此我们就《药典》1995版部份药材的这一问题提出一点看法,以供商榷。
The 1995 edition of the “Chinese Pharmacopoeia” has now been promulgated and implemented, thus making China’s pharmaceutical quality a step closer to a higher level. However, there are still a lot of medicinal herbs due to too few inspection items, and there are still insufficient legislations to ensure the inherent quality of medicinal herbs, which can lead to the proliferation and use of low-quality and low-quality drugs in the production and management of medicinal materials or Chinese patent medicines, ultimately affecting the efficacy of medicines. To this end, we made a point of view on this issue of the “Pharmacopoeia” 1995 version of some medicinal materials for commercial discussion.